KPV: Best for inflammatory pain and conditions Why KPV is superior for inflammation: Extremely potent anti-inflammatory peptide Reduces IL-6, TNF-alpha, other inflammatory markers Modulates immune response Works systemically Best for: Rheumatoid arthritis Autoimmune-related pain Inflammatory bowel disease with pain Chronic systemic inflammation Widespread pain from inflammation Dosing: Injectable: 500-1,000mcg daily subcutaneous Oral: 1-2mg daily for gut-specific inflammation 8-12 weeks minimum Can use long-term Expected results: Week 2-4: Reduced inflammatory markers Week 4-8: Decreased pain levels Week 8-12: Significant inflammation control Comparison to NSAIDs: KPV: Reduces inflammation without stomach damage NSAIDs: Temporary relief, stomach/kidney risks KPV safer long-term BPC-157 for inflammation + tissue healing Why BPC-157 for inflammatory pain: Anti-inflammatory effects Also heals tissue causing inflammation Dual benefit Best for: Inflammatory pain with tissue damage IBD/Crohn's (gut inflammation) General inflammatory conditions Can combine KPV + BPC-157: KPV: Powerful inflammation reduction BPC-157: Tissue healing Together = comprehensive inflammatory pain relief Best peptide for chronic widespread pain Fibromyalgia, chronic pain syndrome, multi-site pain

Unlock exclusive discounts on your NCPA Membership
Join thousands who have already lost weight with Trimi Important safety information Compounded medications are prepared per individual prescription by licensed 503A community sterile compounding pharmacies (VialsRx, Texas State Board of Pharmacy license #35264
This off-label combination requires careful clinical evaluation, individualized timing, and close monitoring to optimize metabolic outcomes while managing potential risks in patients with altered gastrointestinal anatomy
Such restrictive approaches may increase the risk of hypoglycaemia, particularly in patients taking Ozempic alongside other glucose-lowering medications such as sulphonylureas or insulin
Nausea represents the most common side effect during the transition